FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999885721> ?p ?o ?g. }

• W1999885721 abstract "In previous studies nifedipine has been shown to limit infarct size during 24 h of regional ischemia in the dog. Using a closed chest embolization procedure, autoradiographic (141-cerium at onset of ischemia) microsphere risk zone analysis and tetrazolium staining, the ability of nifedipine to influence collateral flow, energy metabolism and infarct size over 48 h was assessed in the dog. A second microsphere (46-scandium), which did not interfere with the autoradiography, was given after 48 h of ischemia to allow temporal changes in flow to be assessed. Transmural biopsies, taken after 48 h from non-ischemic tissue, ischemic tissue which had become necrotic and ischemic tissue which had survived (tetrazolium-positive tissue within the risk zone) were assayed for flow, adenosine triphosphate (ATP) and creatine phosphate (CP). The results indicate: nifedipine may still afford some small degree of protection up to 48 h of elapsed ischemia, (infarct size as a percent of risk zone size was 86.1 +/- 3.0 in control vs 70.4 +/- 4.5 in drug group (p less than 0.025 n = 9 in each group), 'salvage' in both the control and the nifedipine-treated groups was predominantly subepicardial and in the transmural plane. The extent and location of salvage and necrosis was determined by the epicardial to endocardial distribution of collateral flow. In tissue which was destined to necrosis (mainly in the subendocardium) collateral flow at the onset of ischemia (7.2 +/- 1.2% relative to surrounding non-ischemic tissue) did not increase over 48 h (8.0 +/- 1.4) whereas in tissue which was 'salvaged' (mainly in the subepicardium) flow was greater (27.4 +/- 3.2%) at onset of ischemia) and increased substantially (to 64.6 +/- 5.9%) over 48 h; nifedipine does not increase the amount of flow per g of tissue in salvaged tissue but rather it may increase the amount of tissue receiving sufficient flow to promote salvage; it follows that in nifedipine-treated animals more flow is delivered to the ischemic zone; tissue ATP and CP parallel flow and the results support the concept of a critical threshold of flow (approx. 25% at onset of ischemia) below which tissue eventually deteriorates to necrosis and above which tissue is likely to amenable to salvage. However, for sustained survival this flow level must eventually increase to above 40-50%. In conclusion, while nifedipine can achieve a substantial delay in the onset of tissue necrosis, for sustained salvage there must be early and substantial reflow to the tissue." @default.
• W1999885721 created "2016-06-24" @default.
• W1999885721 creator A5010610348 @default.
• W1999885721 creator A5027402408 @default.
• W1999885721 creator A5049153704 @default.
• W1999885721 creator A5051850889 @default.
• W1999885721 creator A5076306963 @default.
• W1999885721 creator A5090808868 @default.
• W1999885721 date "1986-01-01" @default.
• W1999885721 modified "2023-10-05" @default.
• W1999885721 title "Calcium antagonists and evolving myocardial infarction: Studies of the effects ofnifedipine on tissue ATP, collateral flow and infarct size in the closed chest dog" @default.
• W1999885721 cites W166143166 @default.
• W1999885721 cites W181422202 @default.
• W1999885721 cites W1963509070 @default.
• W1999885721 cites W1964392950 @default.
• W1999885721 cites W1976016406 @default.
• W1999885721 cites W1976713885 @default.
• W1999885721 cites W1981531583 @default.
• W1999885721 cites W2001083459 @default.
• W1999885721 cites W2002379747 @default.
• W1999885721 cites W2008832288 @default.
• W1999885721 cites W2009138390 @default.
• W1999885721 cites W2021553590 @default.
• W1999885721 cites W2026717727 @default.
• W1999885721 cites W2033508121 @default.
• W1999885721 cites W2033529886 @default.
• W1999885721 cites W2034880982 @default.
• W1999885721 cites W2044462992 @default.
• W1999885721 cites W2050003797 @default.
• W1999885721 cites W2053807638 @default.
• W1999885721 cites W2054614108 @default.
• W1999885721 cites W2057404390 @default.
• W1999885721 cites W2066349673 @default.
• W1999885721 cites W2068570018 @default.
• W1999885721 cites W2070876793 @default.
• W1999885721 cites W2071099613 @default.
• W1999885721 cites W2079733424 @default.
• W1999885721 cites W2080356707 @default.
• W1999885721 cites W2088385917 @default.
• W1999885721 cites W2094827543 @default.
• W1999885721 cites W2100650600 @default.
• W1999885721 cites W2102896366 @default.
• W1999885721 cites W2113702465 @default.
• W1999885721 cites W2113919815 @default.
• W1999885721 cites W2132924014 @default.
• W1999885721 cites W2147750240 @default.
• W1999885721 cites W2152928050 @default.
• W1999885721 cites W2158445658 @default.
• W1999885721 cites W2171074980 @default.
• W1999885721 cites W2252777310 @default.
• W1999885721 cites W2255081439 @default.
• W1999885721 cites W2269919727 @default.
• W1999885721 cites W2320789612 @default.
• W1999885721 cites W2414124621 @default.
• W1999885721 cites W2417077635 @default.
• W1999885721 cites W2426875752 @default.
• W1999885721 cites W2435960434 @default.
• W1999885721 cites W2469163617 @default.
• W1999885721 doi "https://doi.org/10.1016/s0022-2828(86)80031-1" @default.
• W1999885721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3783744" @default.
• W1999885721 hasPublicationYear "1986" @default.
• W1999885721 type Work @default.
• W1999885721 sameAs 1999885721 @default.
• W1999885721 citedByCount "6" @default.
• W1999885721 crossrefType "journal-article" @default.
• W1999885721 hasAuthorship W1999885721A5010610348 @default.
• W1999885721 hasAuthorship W1999885721A5027402408 @default.
• W1999885721 hasAuthorship W1999885721A5049153704 @default.
• W1999885721 hasAuthorship W1999885721A5051850889 @default.
• W1999885721 hasAuthorship W1999885721A5076306963 @default.
• W1999885721 hasAuthorship W1999885721A5090808868 @default.
• W1999885721 hasConcept C126322002 @default.
• W1999885721 hasConcept C164705383 @default.
• W1999885721 hasConcept C2777798775 @default.
• W1999885721 hasConcept C2779066535 @default.
• W1999885721 hasConcept C2779896295 @default.
• W1999885721 hasConcept C500558357 @default.
• W1999885721 hasConcept C503630168 @default.
• W1999885721 hasConcept C519063684 @default.
• W1999885721 hasConcept C541997718 @default.
• W1999885721 hasConcept C71924100 @default.
• W1999885721 hasConcept C85378888 @default.
• W1999885721 hasConceptScore W1999885721C126322002 @default.
• W1999885721 hasConceptScore W1999885721C164705383 @default.
• W1999885721 hasConceptScore W1999885721C2777798775 @default.
• W1999885721 hasConceptScore W1999885721C2779066535 @default.
• W1999885721 hasConceptScore W1999885721C2779896295 @default.
• W1999885721 hasConceptScore W1999885721C500558357 @default.
• W1999885721 hasConceptScore W1999885721C503630168 @default.
• W1999885721 hasConceptScore W1999885721C519063684 @default.
• W1999885721 hasConceptScore W1999885721C541997718 @default.
• W1999885721 hasConceptScore W1999885721C71924100 @default.
• W1999885721 hasConceptScore W1999885721C85378888 @default.
• W1999885721 hasLocation W19998857211 @default.
• W1999885721 hasLocation W19998857212 @default.
• W1999885721 hasOpenAccess W1999885721 @default.
• W1999885721 hasPrimaryLocation W19998857211 @default.
• W1999885721 hasRelatedWork W1994800264 @default.
• W1999885721 hasRelatedWork W1999885721 @default.
• W1999885721 hasRelatedWork W2007199634 @default.

• next